Oxipit, a medical imaging company, has been awarded an “Intelektas. Bendri mokslo-verslo projektai” EU grant for researching and implementing innovative technologies for improved detection of lung nodules as well as diagnosis of pneumothorax and tuberculosis.
The research project will last from 2019 to 2021. “Intelektas. Bendri mokslo-verslo projektai” is a joint initiative of EU and Lithuanian Government to support the creation of innovative products and cooperation between science and business organizations.
The grant of about 565 418 Eur is provided by the European Regional Development Fund, a European Union initiative aimed to strengthen economic and social cohesion across European regions and foster innovation and research.
The total value of the project is about 730 000 Eur.
The project is funded by the European Regional Development Fund
Instrument: Intelektas. Bendri mokslo–verslo projektai
Project No. J05-LVPA-K-04-0065
Total value: 729 148,45 EUR
Funding recieved: 565 418,90 EUR
Project start: 2019-01-01
Project end: 2021-01-01
Oxipit is a computer vision software startup specialized in medical imaging. With a team of award-winning data scientists and medical doctors, the company aims to introduce innovative Artificial Intelligence/Deep Learning breakthroughs to everyday clinical practice. Oxipit is the authors of CE certified multi-award winning ChestEye radiology imaging suite.